Skip to main content

Table 2 Proportions of antibiotic resistance and combined antibiotic resistance for Escherichia coli obtained from urine samples of healthy pregnant women compared to clinical samples from febrile patients

From: Escherichia coli from urine samples of pregnant women as an indicator for antimicrobial resistance in the community: a field study from rural Burkina Faso

Resistance per antibiotic

Healthy pregnant women

Febrile patients

Urine culture (n = 155)

Urine culture (n = 3) blood culture (n = 45)

n (%)

n = 48 (%)

Nitrofurantoin

6 (3.9%)

Not done

Fosfomycin

0 (0%)

Not done

Ampicillin

102 (65.8%)

43 (89.6%)

Cotrimoxazole

97 (64.4%)

43 (89.6%)

Ciprofloxacin

25 (16.2%)

30 (62.5%)

Gentamicin

6 (3.9%)

11 (22.9%)

Ceftriaxone

5 (3.2%)

18 (37.5%)

ESBL producers

5 (3.2%)

17 (35.4%)

Combined resistance

n (%)

n (%)

Ampicillin + cotrimoxazole

80 (51.6%)

41 (85.4%)

Ampicillin + cotrimoxazole + ciprofloxacin

8 (5.2%)

29 (60.4%)

Ampicillin + cotrimoxazole + gentamicin

3 (1.9%)

11 (22.9%)

Ampicillin + cotrimoxazole + ciprofloxacin + gentamicin

2 (1.3%)

11 (22.9%)

ESBL + cotrimoxazole

2 (1.3%)

17 (35.4%)

ESBL + cotrimoxazole + ciprofloxacin

2 (1.3%)

16 (33.3%)

ESBL + cotrimoxazole + gentamicin

1 (0.6%)

7 (14.5%)

ESBL + cotrimoxazole + ciprofloxacin + gentamicin

1 (0.6%)

7 (14.5%)

  1. Differences in proportions of clinical and urine isolates were assessed using chi-square test. For smaller sample sizes (value in one of the cells ≤ 5), the Fischer exact test was used. All differences between isolates obtained from healthy pregnant women and febrile patients were statistically significant (p < 0.001)
  2. There was no statistical difference in resistance patterns between isolates growing in counts of 104 CFU/ml and 105 CFU/ml